<DOC>
	<DOCNO>NCT01306825</DOCNO>
	<brief_summary>Bone joint infection commonly due Gram-positive bacteria . Treatment infection difficult need prolong duration antimicrobial agent combination surgical procedure . Moreover , recent year , grow resistance pattern various antimicrobial agent observe Gram-positive bacteria . Consequently , urgent need new drug high bone penetration treatment infection . The investigator hypothesize daptomycin allow achieve high concentration bone compartment .</brief_summary>
	<brief_title>Clinical Evaluation Daptomycin Bone Penetration</brief_title>
	<detailed_description />
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Inclusion criterion : Patient treatment daptomycin 3 day dosage 6 mg/kg Patient undergo imperative surgery bone withdrawal Signed , date informed consent define Institutional Review Board Male female patient older 18 year age Patients social insurance Patient information previous mandatory medical examination Exclusion criterion : Patient treatment daptomycin dosage &lt; 6mg/kg less 3 dos daptomycine Patient need surgery Patient young 18 year age Pregnant nursing woman Patient refusal inclusion Patients deprive liberty Inability complete inform consent process problem mental capacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Daptomycin</keyword>
	<keyword>Bone disease , infectious</keyword>
	<keyword>Osteomyelitis</keyword>
	<keyword>Diabetic foot</keyword>
	<keyword>Staphylococcus aureus</keyword>
</DOC>